NEW YORK, July 27 (Reuters) - Shares in Human Genome Sciences fell 2.5 percent to $13.65 in extended trade on Monday after the biopharmaceutical company said it would publicly offer of up to 18 million shares of its common stock.
(Reporting by Edward Krudy) Keywords: MARKETS STOCKS AFTERTHEBELL (Edward.Krudy@thomsonreuters.com; +1-646-223-6314; Reuters Messaging: Edward.Krudy.reuters.com@reuters.net) COPYRIGHT Copyright Thomson Reuters 2009. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
(Reporting by Edward Krudy) Keywords: MARKETS STOCKS AFTERTHEBELL (Edward.Krudy@thomsonreuters.com; +1-646-223-6314; Reuters Messaging: Edward.Krudy.reuters.com@reuters.net) COPYRIGHT Copyright Thomson Reuters 2009. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.